Упрощенная HTML-версия
250.
Drugs acting on imidazoline receptors: a rewiew of their pharmacology, their
use in blood pressure control and their potential interest in cardioprotection / P.
Bousquet [et al.] // Drugs. – 1999. – Vol.58. – P. 799-812.
251.
Duality of angiotensin II receptors and risk for stroke and cancer: what is the
connection / A. Fournier [et al.] // Presse Med. – 1999 . – Vol. 28, № 17. – P.
918-922.
252.
Dubey L. Role of leptin in atherogenesis / L. Dubey, Z. Hesong // Exp. Clin.
Cardiol. 2006. – Vol. 11, № 4. – P. 269 – 275.
253.
Duron E. Vascular risk factors, cognitve decline, and dementia / E. Duron, O.
Hanon // Vasc. Health Risk Manag. – 2008. – Vol. 4, № 2. – P. 363–381.
254.
Effects of Moxonidine on the Sympathetic Nervous System, Blood Pressure,
Plasma Renin Activity, Plasma Aldos, Leptin, and Metabolic Profile in Obese
Hypertensive Patients / A. F. Sanjuliani [et al.] // Journal of Clinical and Basic
Cardiology. – 2004. – Vol. 7 (Issue 1-4). – P. 19-25
255.
Efficacy of moxonidine in the treatment of hypertension in obese,
noncontrolled hypertensive patients / J. Abellan [et al.] // Kidney Int. – 2005. –
Vol. 93. – P. 20-24.
256.
Electroencephalographic sleep profiles before and after cognitive-behavior
therapy of depression / Thase M. E. [et al.] // Arch. Gen. Psychiatry. – 1998. –
Vol. 55, № 2. – P. 138-144.
257.
Elevated blood pressure in relation to overweight and obesity among children
in a rural Canadian community / M. Salvadori [et al.] // Pediatrics. – 2008. –
Vol. 122, № 4. – P. 821-827.
258.
Elliott W. J. Cardiovascular events in hypertension trials of angiotensin
converting-enzyme inhibitors / W. J. Elliott // J. Clin. Hypertens. – 2005. –
Vol. 7 (Suppl.2). – P. 2-4.
259.
Endothelial dysfunction is associated with carotid plaque: a cross-sectional
study from the population based Northern Manhattan Study / T. Rundek [et al.]
// BMC. Cardiovasc. Disord. – 2006. – № 6. – P. 35.